How valid is a prescription-based multimorbidity index (Rx-risk) in predicting mortality in the Outcomes and Multimorbidity In Type 2 diabetes (OMIT) study? A nation-wide registry-based cohort study from Norway

Objective The prescription-based Rx-risk index has previously been developed to measure multimorbidity. We aimed to adapt and evaluate the validity of the Rx-risk index in prediction of mortality among persons with type 2 diabetes.Design Registry-based study.Setting Adults with type 2 diabetes in No...

Descripció completa

Dades bibliogràfiques

Autors principals:	Anne Karen Jenum, Jannicke Igland, Marjolein Memelink Iversen, Jan Ivar Røssberg, Ragnhild B Strandberg, Tore Julsrud Berg, Esben Selmer Buhl, Rachel Forster
Format:	Artigo
Idioma:	Inglês
Publicat:	BMJ Publishing Group 2024-03-01
Col·lecció:	BMJ Open
Accés en línia:	https://bmjopen.bmj.com/content/14/3/e077027.full
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!